欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5511/001
药品名称Teriflunomide Glenmark 14 mg film-coated tablets
活性成分
    • Teriflunomide 14.0 mg
剂型Film-coated tablet
上市许可持有人Glenmark Arzneimittel GmbH Industriestrasse 31 Groebenzell 82194 Germany
参考成员国 - 产品名称Netherlands (NL)
Teriflunomide Glenmark 14 mg filmomhulde tabletten
互认成员国 - 产品名称
    • Poland (PL)
      Teriflunomide Glenmark
    • Germany (DE)
      Teriflumomid Glenmark14 mg Filmtabletten
    • Czechia (CZ)
      Teriflunomide Glenmark
    • Slovakia (SK)
    • Denmark (DK)
      Teriflunomide "Glenmark"
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Latvia (LV)
    • Finland (FI)
    • Lithuania (LT)
      Teriflunomide Glenmark 14 mg plėvele dengtos tabletės
    • Estonia (EE)
    • Hungary (HU)
      Teriflunomide Glenmark 14 mg filmtabletta
    • Norway (NO)
许可日期2023/08/16
最近更新日期2025/09/28
药物ATC编码
    • L04AA31 teriflunomide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase